Destiny Tech100 (DXYZ) Review 2026

TL;DR: Destiny Tech100 (NYSE: DXYZ) lets you buy into SpaceX, OpenAI, and Anthropic through a regular brokerage account with no accreditation required. That access is real. As of May 2026, the fund's stock traded at $61.66 against a net asset value of $24.56, a 151% premium. At its April 2024 peak, buyers paid over 400% above the value of the underlying assets. The SEC filing puts it in black and white. You are paying a very steep price for that access, and you need to know that going in.

What DXYZ Actually Is

Destiny Tech100 Inc. is a closed-end fund, a type of investment company that raises capital through a one-time share offering and then trades those shares on a stock exchange like any other equity. It is not an ETF. It does not continuously create and redeem shares at NAV the way an index fund does. The share price floats on supply and demand, which is exactly how a closed-end fund can trade at a significant premium or discount to the actual value of its holdings.

The fund is structured as a Maryland corporation and elected status as a Regulated Investment Company (RIC) under the Investment Company Act of 1940. Its investment advisor is DX Advisors LLC, founded by Sohail Prasad. DXYZ trades on the NYSE under that ticker. You can buy it in a Roth IRA, a taxable brokerage account, or wherever else you trade stocks.

The access story is genuinely new. Most pre-IPO stakes in companies like SpaceX or Anthropic are restricted to accredited investors, people with a net worth above $1 million (excluding primary residence) or annual income above $200,000. DXYZ sidesteps that requirement entirely. You can buy a single share for whatever the market price is that day. That is the product, and the value proposition is real.

The structural question is what you are actually paying for it.

The Portfolio: What You Are Buying

As of March 31, 2026, DXYZ held approximately $742.5 million in total portfolio value across 36 companies, with roughly 68.6% in private tech issuers. As of December 31, 2025, the breakdown was $228.8 million in private securities and $205.3 million in cash and equivalents. A meaningful portion of the fund sits in cash awaiting deployment.

SpaceX dominates the private-securities side, held through two separate vehicles that together represent about 16.3% of the private portfolio. On January 26, 2026, the fund committed $100 million to Anthropic through a Series B Preferred stake via Magnitude ANC III LLC. Other names include Databricks at approximately 4.0%, Shield AI at 4.1% (through Snowpoint), Beast Industries (the MrBeast holding company) at 3.5%, xAI Corp. at 3.5%, Revolut at 2.9%, and OpenAI at 2.1%.

DXYZ Top Holdings, December 31, 2025

Company	% of Private Securities Portfolio	Notes
SpaceX (combined)	~16.3%	DXYZ SpaceX I LLC and MWAM VC SpaceX-II
Shield AI / Snowpoint	~4.1%	Defense AI
Databricks	~4.0%	Enterprise data and AI platform
Beast Industries	~3.5%	MrBeast holding company
xAI Corp.	~3.5%	Elon Musk's AI company
OpenEvidence	~3.5%	AI for clinical evidence
Revolut	~2.9%	UK fintech neobank
Skild AI	~2.3%	Robotics foundation models
OpenAI	~2.1%	ChatGPT parent company
Anthropic	$100M committed Jan 2026	Series B Preferred; not in the Dec 2025 snapshot

The portfolio also includes Klarna, Chime, Payward (Kraken's parent), Redwood Materials, Axiom Space, Hermeus Corporation, Chaos Industries, and Vast Inc. The concentration in SpaceX at 16.3% is a real concentration risk. If that single position deteriorates for any reason, DXYZ shareholders feel it immediately and significantly.

Private-asset valuations are marked at fair value on a quarterly basis. There is no continuous price discovery for SpaceX the way there is for publicly traded equities. The fund's stated NAV can lag actual market conditions by weeks or months, in either direction.

The Fee Structure

DX Advisors LLC charges a 2.50% annual management fee on average gross assets, not NAV. That distinction matters. The fee base stays elevated regardless of how much cash the fund holds or how the private-asset valuations move. The 2024 N-CSR shareholder report shows a total expense ratio of approximately 6.28% of average net assets for that period.

To put that number in context: broad-market index funds charge 0.03% to 0.20%. Actively managed equity funds rarely exceed 1.5%. At 6.28%, DXYZ is in a different cost category entirely. Every year you hold the fund, roughly 6 cents of every dollar of NAV-equivalent exposure goes to fund expenses. The premium compounds this problem. If you paid $61.66 for $24.56 worth of assets, your effective ongoing cost as a share of what you actually paid is even higher than the stated expense ratio implies.

The Premium-to-NAV Problem

NAV stands for net asset value: the per-share value of everything the fund owns, minus its liabilities, divided by total shares outstanding. In a mutual fund, you always buy and sell at NAV. In a closed-end fund, the market price is determined by buyer and seller activity on the exchange, and that price can diverge widely from NAV.

DXYZ's premium history is extreme. In April 2024, shares traded near $105 against a NAV of approximately $4.84. CNBC reported the 400%-plus premium in real time. The premium has since compressed, but the May 2026 SEC 424B5 filing still shows a market price of $61.66 against a NAV of $24.56, a 151% premium.

Here is the practical math. Suppose the DXYZ portfolio doubles in value. SpaceX goes public at a strong valuation, Anthropic has a breakout year. The NAV rises from $24.56 to $49.12. If you bought at $61.66, you still lost money. The portfolio needs to increase by approximately 2.5 times just for your purchase price to break even on NAV, and that is before the 6.28% annual expense ratio erodes the underlying value each year you hold.

The fund has attempted to compress the premium through share issuances. In Q4 2025, DXYZ sold 8.12 million new shares through an at-the-market offering, generating approximately $244.6 million in net proceeds. The fund is authorized to issue up to $1 billion in new shares. New issuances can narrow a premium by increasing supply, but they also dilute existing holders. Track the premium and discount history on Morningstar before you buy or add to a position.

How DXYZ Compares to SPV Marketplaces

If you are an accredited investor, you have alternatives. EquityZen, Forge Global, and Hiive are secondary marketplaces where you can buy individual stakes in private companies directly, or through a special purpose vehicle (SPV) built around a single company. The cost model is fundamentally different: typically a one-time transaction fee of 3% to 5%, with no ongoing annual expense ratio dragging at your position year after year.

DXYZ vs. SPV Marketplaces: Key Comparison

Feature	DXYZ (Closed-End Fund)	EquityZen / Forge / Hiive (SPV Marketplaces)
Accreditation required?	No, open to all investors	Yes, accredited investors only
Minimum investment	One share (~$61 at May 2026 price)	Typically $10,000 to $50,000 or more
Liquidity	High, trades daily on the NYSE	Low, locked until IPO or acquisition
Ongoing cost	~6.28% total expense ratio (2024)	3 to 5% one-time fee, no annual drag
Premium to assets	~151% as of May 2026	None, you transact near fair market value
Diversification	36 companies per share	Single-company exposure per transaction
Valuation updates	Quarterly NAV calculation	Transaction price reflects current market bids

The tradeoff is direct. SPV platforms require accreditation, larger minimums, and you accept illiquidity. Your capital stays locked until the company exits. DXYZ is liquid and accessible to anyone. For an accredited investor with the capital to participate in SPV platforms, the math usually favors them: you pay once, you own the asset (or a vehicle that does), and you do not pay 6% annually for someone to manage your exposure. For a non-accredited investor, DXYZ is one of the only practical options for this kind of pre-IPO exposure. That is precisely its purpose.

Jeff's Verdict

Here is my read. DXYZ solves a real problem. It gives non-accredited investors direct exposure to the most talked-about private companies in tech without requiring them to be wealthy first. The names inside the fund are genuinely impressive and genuinely hard to replicate on your own without a seven-figure portfolio. The December 2025 prospectus supplement and the 2025 annual report make the fund's structure and risks transparent. Nothing is hidden.

But a 151% premium is not a minor rounding error. If the premium compresses back toward zero (and closed-end fund premiums historically do compress over time), you can lose money even if every company inside the portfolio thrives. That happened to people who bought in April 2024 and held through the correction from a 400%-plus premium. The expense ratio compounds the structural disadvantage: 6.28% per year is a significant headwind against any projected return from private-tech holdings.

DXYZ makes the most sense as a small, speculative allocation for a non-accredited investor who wants any exposure to pre-IPO tech and understands what they are actually paying for. It does not make sense as a core portfolio holding. It does not make sense at a 150%-plus premium for an accredited investor who can access the underlying companies more cheaply elsewhere. If you buy it, size it accordingly. This is a high-fee, high-premium, concentrated-private-tech bet. Go in with your eyes open, watch the premium regularly, and do not mistake access for value.

Frequently Asked Questions

Is DXYZ a good investment in 2026?

At a 151% premium to NAV as of May 2026, DXYZ is priced aggressively. The underlying portfolio holds compelling companies, but you are paying $61.66 for approximately $24.56 worth of assets. That portfolio needs to increase in value by roughly 2.5 times just for your purchase price to be covered by NAV alone, and the ~6.28% annual expense ratio erodes returns further every year you hold. Whether DXYZ makes sense depends on whether you are a non-accredited investor with no other path to this exposure and whether you treat it as a small, speculative allocation rather than a portfolio foundation.

What is the difference between DXYZ's market price and its NAV?

NAV (net asset value) is the per-share value of everything the fund owns minus its liabilities, essentially what the fund is actually worth on a per-share basis. Because DXYZ is a closed-end fund that trades on the NYSE, its market price is set by supply and demand between buyers and sellers rather than by the underlying asset value. When demand for DXYZ shares is high, driven by enthusiasm about the companies inside the portfolio, the market price can trade far above NAV. That gap is called a premium. At DXYZ's April 2024 peak, the premium exceeded 400%. As of May 2026, it stood at approximately 151%, still a very large gap by any historical standard for closed-end funds.

Who can invest in DXYZ?

Any investor with a brokerage account can buy DXYZ shares. There is no accredited-investor requirement, no minimum investment beyond the cost of a single share, and no lockup period. This is what makes DXYZ structurally different from most pre-IPO investment vehicles, which require you to meet SEC thresholds such as a net worth above $1 million excluding your primary residence or annual income above $200,000. DXYZ removes that barrier entirely and trades on the NYSE exactly like any other public stock.

Are there cheaper ways to invest in pre-IPO companies?

If you qualify as an accredited investor, platforms like EquityZen, Forge Global, and Hiive let you buy individual stakes in private companies through special purpose vehicles for a one-time transaction fee of roughly 3 to 5%, with no ongoing annual expense ratio. You accept illiquidity (your capital is locked until the company has an exit event), but you transact near fair market value without a 150%-plus premium, and you are not paying 6% per year for a fund manager to hold the assets on your behalf. For non-accredited investors, DXYZ is currently one of the only practical options for this type of exposure, which is the core reason the fund exists.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.